September 2025 Volume 21, Issue 3


Volume 21, Issue 3 | September 2025
September 2025
In this Issue
Cell Therapy

New clinical trial puts in vivo CAR T cells to the test
Two ongoing Phase 1 trials will produce the first human data on these potentially revolutionary cancer drugs.
CAR T cells: The last line of defense against childhood leukemia
Scientists are advancing CAR T cell therapy to improve outcomes for children with acute lymphoblastic leukemia.Spatial Biology

Kidney disease research grows in a dish
Animal and cell culture models have fallen short in kidney disease research. Kidney organoids may offer a better way forward.
T cells may drive transition to cancer in colorectal tumors
New research suggests an unexpected role for T cells during a tumor’s evolution from benign to malignant.Drug Formulation

Uncovering new approaches to prevent malaria
Strategies including parasite-based vaccines, mosquito-transmission blockers, and antibody drugs are promising new ways to target the disease.
New vaccine pills could replace intramuscular shots
Vaxart aims to revolutionize immunization by replacing injections with easy-to-take tablets.Diagnostics







